Rethinking Remdesivir
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.